Transplant News and Research

RSS

Experimental stem cell treatment improves vision in blind mice

An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.

3 Oct 2012

Novel therapy shows promise in treating multiple myeloma following stem cell transplants

A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system.

2 Oct 2012

Five prominent surgeons receive Honorary Fellowship from ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to five prominent surgeons from Japan, the Philippines, Mexico, England, and Belgium during Convocation ceremonies that preceded the official opening of the 2012 ACS Annual Clinical Congress.

1 Oct 2012

Health policies bubble up in House and Senate races

The Associated Press reports on how the top of the ticket could affect some down-ballot races, and other news outlets report on how Medicare is playing in Virginia, Nevada and Wisconsin races.

29 Sep 2012

Nearly 20% of people develop PTSD symptoms after low back fusion surgery

Nearly 20 percent of people who underwent low back fusion surgery developed post-traumatic stress disorder symptoms associated with that surgery, according to a recent Oregon Health & Science University study published in the journal Spine.

29 Sep 2012

Most Canadians view financial incentives for deceased kidney donation to be acceptable

Most Canadians view financial incentives for deceased kidney donation to be acceptable, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

28 Sep 2012

First Edition: September 28, 2012

Today's headlines include reports about political and policy-oriented health care developments.

28 Sep 2012

Three USU doctoral students to receive Henry M. Jackson Fellowships

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has selected three promising Uniformed Services University of the Health Sciences (USU) doctoral students to receive fellowships for the 2012-13 academic year. The program, established in 1988, includes two Henry M. Jackson Fellowships and one Val G. Hemming Fellowship. Each fellow receives a stipend and travel support.

28 Sep 2012

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

28 Sep 2012

Researchers reduce life-threatening complication of stem cell transplants in mice with leukemia

Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns.

28 Sep 2012

Thymus tissue, iPSCS and liver cells can thrive in lymph nodes

Lymph nodes can provide a suitable home for a variety of cells and tissues from other organs, suggesting that a cell-based alternative to whole organ transplantation might one day be feasible, according to researchers at the University of Pittsburgh School of Medicine and its McGowan Institute for Regenerative Medicine.

28 Sep 2012

Go Daddy donates $10,000 for Scottsdale Healthcare Cancer Center fundraiser

GoDaddy.com, the world's largest provider of Web hosting and domain name registrations, is donating $10,000 to help cancer patients and kick-start fundraising for the 4th annual Scottsdale Healthcare Rob Moy Memorial Motorcycle Run.

27 Sep 2012

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.

27 Sep 2012

Cell Banker 3 cryopreservation solution effectively preserves iPSCs

In a study to determine the best cryopreservation (freezing) solution to maintain induced pluripotent stem (iPS) cells, a team of researchers from Japan compared 12 kinds of commercially prepared and readily available cryopreservation solutions and found that "Cell Banker 3" out-performed the other 11 solutions by allowing iPS cells to be preserved for a year at -80 degrees C in an undifferentiated state.

26 Sep 2012

Researchers identify several kinase inhibitors that help generate many iPSCs

The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.

26 Sep 2012

UC Medicine nurses to administer free flu shots to licensed taxicab drivers at O'Hare Midway

As part of an initiative to vaccinate some of Chicago's most vulnerable populations, University of Chicago Medicine nurses will administer free flu shots to licensed taxicab drivers at O'Hare International Airport on Tuesday, Sept. 25, and at Midway International Airport the following Tuesday, Oct. 2. Up to 1,000 cabbies could be vaccinated over the two days.

25 Sep 2012

Bone marrow transplants hold promise for sickle cell patients

Research shows that even partially matched bone marrow transplants are able to eliminate sickle cell disease in some patients with sickle cell anemia.

24 Sep 2012

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.

24 Sep 2012

$Encouraging results from CTI’s pacritinib phase 1 study on relapsed/refractory lymphoma$

Encouraging results from CTI’s pacritinib phase 1 study on relapsed/refractory lymphoma

Cell Therapeutics, Inc. announced today that the phase 1 study data of its highly selective oral JAK2 inhibitor pacritinib, or SB1518, showed encouraging anti-tumor activity and good tolerability in 34 patients with relapsed/refractory lymphoma.

24 Sep 2012

Even partially matched bone marrow transplants can eliminate sickle cell disease in some patients

In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms and the need for a lifetime of pain medications and blood transfusions.

24 Sep 2012

Transplant News and Research

Experimental stem cell treatment improves vision in blind mice

Novel therapy shows promise in treating multiple myeloma following stem cell transplants

Five prominent surgeons receive Honorary Fellowship from ACS

Health policies bubble up in House and Senate races

Nearly 20% of people develop PTSD symptoms after low back fusion surgery

Most Canadians view financial incentives for deceased kidney donation to be acceptable

First Edition: September 28, 2012

Three USU doctoral students to receive Henry M. Jackson Fellowships

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Researchers reduce life-threatening complication of stem cell transplants in mice with leukemia

Thymus tissue, iPSCS and liver cells can thrive in lymph nodes

Go Daddy donates $10,000 for Scottsdale Healthcare Cancer Center fundraiser

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Cell Banker 3 cryopreservation solution effectively preserves iPSCs

Researchers identify several kinase inhibitors that help generate many iPSCs

UC Medicine nurses to administer free flu shots to licensed taxicab drivers at O'Hare Midway

Bone marrow transplants hold promise for sickle cell patients

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Encouraging results from CTI’s pacritinib phase 1 study on relapsed/refractory lymphoma

Even partially matched bone marrow transplants can eliminate sickle cell disease in some patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News